as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹2,888.5
Change
+108.3 (3.9%)
Open
₹2,799.0
Prev. Close
₹2,780.2
Day High
₹2,905.0
Day Low
₹2,763.6
Volume Analysis
Traded
186,365
Delivered
61,157
Delivery %
32.82%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Trading within 3% of its 52-week high (₹2875.0)
Weaknesses (4)
- •High debt-to-equity ratio (1.04)
- •Low return on equity (3.58%)
- •Promoter holding is falling
- •Below-average fundamentals quality score (48/100)
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹3,082.54 | ₹2,993.77 | ₹2,941.14 | ₹2,852.37 | ₹2,799.74 | ₹2,710.97 | ₹2,658.34 |
| Fibonacci | ₹2,993.77 | ₹2,939.76 | ₹2,906.38 | ₹2,852.37 | ₹2,798.36 | ₹2,764.98 | ₹2,710.97 |
| Camarilla | ₹2,927.39 | ₹2,914.42 | ₹2,901.46 | ₹2,852.37 | ₹2,875.54 | ₹2,862.58 | ₹2,849.62 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+145.62%
1 Week
+1.13%
1 Month
+22.4%
3 Months
+29.52%
6 Months
+71.21%
1 Year
+127.55%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹358.83
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
2.21%
Net margin 3.95% × asset turnover 0.22x × equity multiplier 2.54x
Company Overview
Sector
Chemicals
Market Cap
₹8,526 Cr
P/E (TTM)
211.0
ROE
3.58%
Book Value
₹525.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.
TopFund Analysis
Neogen Chemicals Limited scores weakly on TopFund's composite fundamentals check within the Chemicals sector, at 48/100. The strongest factor is Momentum (98/100), while Cash Flow (0/100) is the weakest area to weigh before deciding. Notably: Trading within 3% of its 52-week high (₹2875.0); high debt-to-equity ratio (1.04); low return on equity (3.58%).
TopFund Score — Fundamentals Quality
48/100 — WeakData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company is expected to give good quarter
- +Company's median sales growth is 20.3% of last 10 years
- +Company's working capital requirements have reduced from 112 days to 84.6 days
- −Stock is trading at 5.40 times its book value
- −Company has low interest coverage ratio.
- −Promoter holding has decreased over last quarter: -4.69%
- −Company has a low return on equity of 4.90% over last 3 years.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Director’s spouse sold 900 shares on November 17, 2026, for Rs 24.43 lakh.
GPCB revoked fire-related direction and granted CC&A amendment for Dahej plant on November 7, 2026.
GPCB revoked Dahej fire-related direction and granted provisional CC&A amendment effective November 7, 2026.
Director's HUF sold 2,361 Neogen shares on November 5-6, 2026.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 162 | 164 | 200 | 180 | 193 | 201 | 203 | 187 | 209 | 220 | 247 | 250 | 296 |
| Expenses + | 136 | 144 | 164 | 149 | 159 | 167 | 166 | 155 | 179 | 188 | 203 | 202 | 251 |
| Operating Profit | 26 | 20 | 36 | 31 | 35 | 35 | 36 | 32 | 30 | 32 | 44 | 48 | 45 |
| OPM % | 16.03% | 12.34% | 17.93% | 17.12% | 17.85% | 17.2% | 17.94% | 16.87% | 14.36% | 14.5% | 17.81% | 19.27% | 15.31% |
| Other Income + | 2 | 2 | 2 | 2 | 1 | 1 | -13 | 1 | 2 | 2 | 1 | 4 | 4 |
| Interest | 11 | 11 | 10 | 10 | 13 | 13 | 13 | 13 | 19 | 22 | 21 | 21 | 28 |
| Depreciation | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 6 | 7 | 7 | 8 | 8 | 9 |
| Profit before tax | 11 | 6 | 22 | 16 | 15 | 15 | 4 | 14 | 5 | 6 | 16 | 23 | 13 |
| Tax % | 27.87% | 81.4% | 24.66% | 27.22% | 29.2% | 34.36% | 34.51% | 28.2% | 34.56% | 35.94% | 28.14% | 26.5% | 35.3% |
| Net Profit + | 8 | 1 | 17 | 11 | 11 | 10 | 2 | 10 | 3 | 4 | 11 | 17 | 8 |
| EPS in Rs | 3 | 0 | 6 | 4 | 4 | 4 | 1 | 4 | 1 | 1 | 4 | 6 | 3 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | 9 | -12 | -2 | 9 | 20 | 22 | 2 | 4 | 8 | 9 | 22 | 34 | 42 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 84 | 100 | 110 | 161 | 239 | 306 | 336 | 487 | 686 | 691 | 778 | 862 | 1,013 |
| Expenses + | 71 | 86 | 90 | 132 | 196 | 248 | 272 | 401 | 575 | 581 | 641 | 725 | 843 |
| Operating Profit | 13 | 14 | 20 | 29 | 43 | 58 | 64 | 87 | 112 | 110 | 136 | 137 | 169 |
| OPM % | 15.0% | 14.0% | 18.0% | 18.0% | 18.0% | 19.0% | 19.0% | 18.0% | 16.0% | 16.0% | 18.0% | 16.0% | 17.0% |
| Other Income + | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 5 | 8 | -10 | 6 | 11 |
| Interest | 5 | 5 | 8 | 10 | 12 | 12 | 14 | 19 | 29 | 42 | 48 | 75 | 92 |
| Depreciation | 1 | 1 | 1 | 2 | 3 | 5 | 7 | 12 | 16 | 23 | 28 | 28 | 31 |
| Profit before tax | 8 | 8 | 12 | 17 | 29 | 41 | 44 | 57 | 71 | 53 | 50 | 41 | 58 |
| Tax % | 37.0% | 39.0% | 33.0% | 37.0% | 28.0% | 30.0% | 29.0% | 22.0% | 30.0% | 32.0% | 31.0% | 30.0% | — |
| Net Profit + | 5 | 5 | 8 | 11 | 21 | 29 | 31 | 45 | 50 | 36 | 35 | 29 | 40 |
| EPS in Rs | 3 | 3 | 4 | 5 | 10 | 12 | 13 | 18 | 20 | 14 | 13 | 11 | 15 |
| Dividend Payout % | 18.0% | 17.0% | 0.0% | 18.0% | 14.0% | 16.0% | 17.0% | 15.0% | 15.0% | 15.0% | 8.0% | 18.0% | — |
| Sales growth | 14 | 20 | 10 | 46 | 48 | 28 | 10 | 45 | 41 | 1 | 13 | 11 | 27 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 19 | 8 | 22 | 30 | 50 | 133 | 160 | 414 | 458 | 734 | 763 | 790 | 1,547 |
| Borrowings + | 24 | 26 | 69 | 82 | 120 | 137 | 222 | 229 | 370 | 409 | 597 | 1,395 | 1,641 |
| Other Liabilities + | 21 | 26 | 41 | 48 | 56 | 61 | 87 | 131 | 202 | 292 | 361 | 691 | 787 |
| Total Liabilities | 69 | 80 | 152 | 180 | 246 | 355 | 492 | 799 | 1,054 | 1,461 | 1,747 | 2,902 | 4,005 |
| Fixed Assets + | 13 | 17 | 56 | 67 | 83 | 111 | 127 | 285 | 347 | 496 | 404 | 475 | 626 |
| CWIP | 0 | 1 | 1 | 1 | 0 | 3 | 115 | 11 | 36 | 109 | 156 | 857 | 1,187 |
| Investments | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 82 | 77 | 0 | 0 | 0 | 0 |
| Other Assets + | 55 | 62 | 94 | 112 | 163 | 241 | 250 | 422 | 594 | 856 | 1,187 | 1,570 | 2,191 |
| Total Assets | 69 | 80 | 152 | 180 | 246 | 355 | 492 | 799 | 1,054 | 1,461 | 1,747 | 2,902 | 4,005 |
| Equity Capital | 4 | 20 | 20 | 20 | 20 | 23 | 23 | 25 | 25 | 26 | 26 | 26 | 30 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 9 | 9 | 0 | 12 | -4 | -35 | 84 | 1 | -30 | -29 | 196 | -231 |
| Cash from Investing Activity + | -2 | -4 | -33 | -13 | -20 | -29 | -135 | -146 | -94 | -216 | -317 | -410 |
| Cash from Financing Activity + | -6 | -4 | 33 | 0 | 24 | 63 | 51 | 188 | 100 | 237 | 113 | 642 |
| Net Cash Flow | 1 | 0 | 1 | -1 | 0 | -1 | 0 | 44 | -25 | -8 | -8 | 0 |
| Free Cash Flow | 7 | 4 | -33 | -1 | -24 | -63 | -51 | -65 | -134 | -332 | -121 | -647 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 89 | 83 | 21 | 55 | 4 | -38 | 146 | 13 | -17 | -18 | 153 | -154 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 15.75% | 16.42% | 15.93% | 18.12% | 18.51% | 18.22% | 18.45% | 18.4% | 22.21% | 21.67% | 23.27% | 24.07% |
| Promoters | 56.89% | 56.89% | 56.89% | 51.22% | 51.22% | 51.22% | 51.22% | 51.22% | 51.22% | 51.22% | 53.0% | 48.31% |
| FII | 4.51% | 4.56% | 4.65% | 8.17% | 7.73% | 7.79% | 7.35% | 5.15% | 4.57% | 4.46% | 4.11% | 4.13% |
| DII | 22.85% | 22.14% | 22.54% | 22.48% | 22.52% | 22.75% | 22.96% | 25.22% | 21.99% | 22.65% | 19.6% | 23.48% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Neogen Chemicals Limited (this stock) | 8,526 | 211.0 | 5.41 | 3.58% |
| Alkyl Amines Chem. Ltd | 8,235 | 43.4 | 15.33 | 41.4% |
| Galaxy Surfactants Ltd | 7,852 | 18.8 | 2.64 | 10.9% |
| Sudarshan Chemical Inds L | 9,219 | 61.2 | 2.52 | 0.54% |
| Jubilant Ingrevia Limited | 9,340 | 26.0 | 2.82 | 9.52% |
| Clean Science & Tech Ltd | 7,524 | 32.3 | 4.5 | 15.3% |
| Swan Corp Limited | 7,288 | 9.92 | 0.94 | -4.5% |
Which Mutual Funds Hold Neogen Chemicals Limited?
Frequently Asked Questions about Neogen Chemicals Limited
Neogen Chemicals Limited (NEOGEN) closed at ₹2,888.5 on NSE on 19 November 2026, up 108.3 (3.9%) from the previous close.
Neogen Chemicals Limited trades on the NSE (National Stock Exchange of India) under the symbol NEOGEN.
Neogen Chemicals Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 211.0.
Neogen Chemicals Limited has a dividend yield of 0.04%.
Neogen Chemicals Limited's 52-week high is ₹2,875.0 and its 52-week low is ₹967.0.
Neogen Chemicals Limited has a market capitalisation of ₹8,526 crore.
Neogen Chemicals Limited has a TopFund Quality Score of 48/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Neogen Chemicals Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.